Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination
(Q77639628)
scientific article published on 01 February 2002
scientific article published on 01 February 2002
Language:
other details
description | scientific article published on 01 February 2002 |
External Links
(P356) |
10.1200/JCO.2002.20.4.1000
|
(P698) |
11844823
|